These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8813270)

  • 1. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.
    Hahn AF; Bolton CF; Pillay N; Chalk C; Benstead T; Bril V; Shumak K; Vandervoort MK; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1055-66. PubMed ID: 8813270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.
    Doneddu PE; Cocito D; Fazio R; Benedetti L; Peci E; Liberatore G; Falzone YM; Germano F; Gallia F; Giannotta C; Lleixà C; Bianchi E; Nobile-Orazio E
    J Neurol Neurosurg Psychiatry; 2024 May; ():. PubMed ID: 38729746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF; Bolton CF; Zochodne D; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Thompson N; Choudhary P; Hughes RA; Quinlivan RM
    J Neurol; 1996 Mar; 243(3):280-5. PubMed ID: 8936360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of relapse and remission of CIDP in a Chinese cohort.
    Niu J; Zhang L; Hu N; Cui L; Liu M
    BMJ Neurol Open; 2024; 6(1):e000651. PubMed ID: 38770161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks.
    Rajabally YA
    Immunotargets Ther; 2024; 13():99-110. PubMed ID: 38435981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives.
    van Doorn IN; Eftimov F; Wieske L; van Schaik IN; Verhamme C
    Ther Clin Risk Manag; 2024; 20():111-126. PubMed ID: 38375075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-Effect Relationship of Motor Nerve Inexcitability on Outcome in Guillain-Barré Syndrome: A Prospective Cohort Study.
    Kumar M; Tiwari A; Kumar S; Singh R
    Ann Indian Acad Neurol; 2023; 26(6):936-942. PubMed ID: 38229619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis in the ICU.
    Hussein G; Liu B; Yadav SK; Warsame M; Jamil R; Surani SR; Khan SA
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States.
    Mallick R; Carlton R; Van Stiphout J
    Pharmacoecon Open; 2023 Mar; 7(2):243-255. PubMed ID: 36757567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept.
    Oh S; Payne AS
    Immune Netw; 2022 Oct; 22(5):e37. PubMed ID: 36381961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.
    Koneczny I; Tzartos J; Mané-Damas M; Yilmaz V; Huijbers MG; Lazaridis K; Höftberger R; Tüzün E; Martinez-Martinez P; Tzartos S; Leypoldt F
    Front Immunol; 2022; 13():834342. PubMed ID: 35401530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
    Querol L; Lleixà C
    Neurotherapeutics; 2021 Oct; 18(4):2222-2235. PubMed ID: 34549385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.
    Malik A; Berry R; Fung BM; Tabibian JH
    Clin J Gastroenterol; 2021 Feb; 14(1):1-13. PubMed ID: 33146871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
    Lewis RA; Cornblath DR; Hartung HP; Sobue G; Lawo JP; Mielke O; Durn BL; Bril V; Merkies ISJ; Bassett P; Cleasby A; van Schaik IN;
    J Peripher Nerv Syst; 2020 Sep; 25(3):230-237. PubMed ID: 32627277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THERAPEUTIC PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN SEVERE NEUROIMMUNE DISORDERS.
    Roman-Filip C; Catană MG; Bereanu A; Lăzăroae A; Gligor F; Sava M
    Acta Clin Croat; 2019 Dec; 58(4):621-626. PubMed ID: 32595246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
    Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
    Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety.
    Liu X; Treister R; Lang M; Oaklander AL
    Ther Adv Neurol Disord; 2018; 11():1756285617744484. PubMed ID: 29403541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment.
    Ellrichmann G; Gold R; Ayzenberg I; Yoon MS; Schneider-Gold C
    Ther Adv Neurol Disord; 2017 Feb; 10(2):91-101. PubMed ID: 28382108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.